Roche reports positive topline outcomes from DMD treatment trial

Roche reports positive topline outcomes from DMD treatment trial

Source: 
Clinical Trials Arena
snippet: 

Roche has reported positive topline outcomes from the second year of the multinational Phase III EMBARK trial of Elevidys (delandistrogene moxeparvovec) as a gene therapy for treating Duchenne muscular dystrophy (DMD).